HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

tyrosyl-prolyl-arginine

synthetic tripeptide; enhances myocardial tolerance to global ischemia & reperfusion lesions

Also Known As:

Tyr-Pro-Arg

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - tyrosyl-prolyl-arginine: 2

Related Diseases

1.	Myocardial Ischemia (Ischemic Heart Diseases) 06/01/1989 - "The synthetic tripeptide Tyr-Pro-Arg was tested for its cardioprotective effect when added to the cardioplegic solution or when used during reperfusion (R) after "global myocardial ischemia" (GMI). "
2.	Ischemia 03/01/1990 - "It was demonstrated in experiments on male Wistar rats that preliminary use of a perfusion liquid containing the synthetic tripeptide Tyr-Pro-Arg facilitates restoration of the indices of the function of isolated perfused hearts (IPH) of rats after stress caused by 30-minute total ischemia (TI) of the myocardium at 37 degrees C. "

Related Drugs and Biologics

1.	Cardioplegic Solutions